DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib

Gastroenterology (2011) - Comments
pubmed: 21741919 doi: 10.1053/j.gastro.2011.06.070 issn: 1528-0012 issn: 0016-5085

Shoumin Zhu, Abbes Belkhiri, Wael El-Rifai